4.1 Article

Development of a clinical prediction model for recurrence and mortality outcomes after Clostridioides difficile infection using a machine learning approach

期刊

ANAEROBE
卷 77, 期 -, 页码 -

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.anaerobe.2022.102628

关键词

Clostridioides dif ficile infection; Machine learning; Logistic regression; Clinical prediction model; Recurrence

向作者/读者索取更多资源

This study used data from Japanese patients to develop machine learning and logistic regression models for predicting recurrent CDI and mortality. The machine learning model performed slightly better than logistic regression in predicting recurrence, while logistic regression was slightly better for predicting mortality.
Objectives: Clostridioides difficile infection (CDI) is associated with a large burden of morbidity and mortality worldwide. Previous studies have developed models for predicting recurrence and mortality following CDI, but no machine learning predictive models have been developed specifically using data from Japanese patients.Methods: Using a database of records from acute care hospitals in Japan, we extracted records from January 2012 to September 2016 (plus a 60-day lookback window). A total of 19,159 patients were included. We used a machine learning approach, XGBoost, and compared it to a traditional unregularized logistic regression model. The first 80% of the dataset (by patient index date) was used to optimize model hyperparameters and train the final models, and evaluation was performed on the remaining 20%. We measured model performance by the area under the receiver operator curve and assessed feature importance using Shapley additive explanations.Results: Performance was similar between the machine learning approach and the classical logistic regression model. Logistic regression performed slightly better than XGBoost for predicting mortality.Conclusion: XGBoost performed slightly better than logistic regression for predicting recurrence, but it was not competitive with existing published models. Despite this, a future machine learning-based application provided in a bedside setting at low cost might be a clinically useful tool.(c) 2022 Merck Sharp & Dohme LLC., a subsidiary Merck & Co., Inc., Rahway, NJ, USA and The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据